Delivery Order SPE2DR25D1100-SPE2DR26FCW8A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,373.02 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. The contract, awarded on December 29, 2025, with an ultimate completion date of December 30, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,988.80 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This firm fixed price, non-set-aside contract is scheduled for ultimate completion on December 16, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,298.88 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The award was competitively executed and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,751.97 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 11, 2025, with a completion date of December 12, 2025. This non-competitive delivery order represents a firm fixed price transaction performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $2,995.68 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by December 31, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract, valued at $1,099.36, represents a firm fixed price delivery order with an ultimate completion date of December 16, 2025. This award was not set aside for small business or other socioeconomic categories and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,716.12 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (100-count units) with a completion date of December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packages) with a ceiling value of $1,890.00. This firm fixed-price delivery order is set to be completed by December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside designation, issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on August 18, 2025, with a ceiling value of $8,385.46. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order contains no set-aside designation, allowing full and open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, valued at $1,497.84, represents a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition without a set-aside...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCW8ADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,512.00 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules (100 count units) under a firm fixed price contract. The delivery order, issued on December 30, 2025, with an ultimate completion date of December 31, 2025, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This contract was awarded without a set-aside designation, indicating it was competitively awarded through open competition. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated extensive capability in fulfilling federal medical procurement requirements across multiple therapeutic domains, making it a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/29/25 |